FIELD: cancer therapy.
SUBSTANCE: use of a ferritin nanoparticle containing the chemotherapeutic agent doxorubicin in the treatment of cancer relapse is proposed to reduce the cardiotoxicity caused by doxorubicin chemotherapy.
EFFECT: invention provides effective treatment of cancer while reducing the cardiotoxicity of chemotherapy.
3 cl, 3 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NANOPARTICLE BASED, TUMOUR-TARGETED DELIVERY OF MEDICINAL AGENTS | 2011 |
|
RU2593367C2 |
| TARGETED EXPOSURE TO TRASTUZUMAB-RESISTANT HER2+ BREAST CANCER BY HER3-TARGETED NANOPARTICLES | 2015 |
|
RU2692104C2 |
| METHOD FOR USING VASOPRESSIN ANTAGONISTS WITH ANTRACYCLINE CHEMOTHERAPEUTIC AGENTS WITH REDUCED CARDIOTOXICITY AND/OR IMPROVED SURVIVAL RATE | 2008 |
|
RU2470643C2 |
| PHARMACEUTICAL COMPOSITIONS AND METHODS FOR CONTROLLING CARDIOTOXICITY CAUSED BY CHEMOTHERAPY | 2017 |
|
RU2743433C2 |
| METHOD OF COMBINED THERAPY FOR CONNECTIVE TISSUE SARCOMA M-1 IN RATS USING A CONJUGATE OF DIPROPOXYBACTERIOPURPURIN WITH DOXORUBICIN | 2023 |
|
RU2808909C1 |
| METHOD FOR IMPROVING IMMUNE CELL FUNCTION AND EVALUATING MULTIFUNCTIONALITY OF IMMUNE CELLS | 2015 |
|
RU2731098C2 |
| TREATING CANCER WITH COMBINATION OF RADIATION THERAPY, CERIUM OXIDE NANOPARTICLES AND CHEMOTHERAPEUTIC AGENT | 2015 |
|
RU2704811C2 |
| METHOD OF TREATING A DISEASE USING A COMPOUND HAVING AN EFFECT ON GLYCOLYSIS | 2016 |
|
RU2723215C2 |
| RECEPTOR TARGETING CONSTRUCTS AND USES THEREOF | 2015 |
|
RU2682335C2 |
| METHOD FOR TREATING ONCOLOGICAL DISEASES | 2018 |
|
RU2675233C1 |
